Recent advances and future directions in the management of hepatitis C infections
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference100 articles.
1. Nanoparticle delivery systems for HCV treatment: do nanoparticles avoid uptake by erythrocytes?;Abo-zeid,2013
2. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994;Alter;N Engl J Med,1999
3. Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trial;Alvarez-Lajonchere;J Viral Hepat,2009
4. HCV-specific immune responses induced by CIGB-230 in combination with IFN-α plus ribavirin;Amador-Cañizares;World J Gastroenterol,2014
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Outcomes of Direct-Acting Antiviral Treatment of Psychiatric Patients with Comorbid Hepatitis C Virus Infection;Digestive Diseases;2019-09-06
2. Viramidine-Loaded Galactosylated Nanoparticles Induce Hepatic Cancer Cell Apoptosis and Inhibit Angiogenesis;Applied Biochemistry and Biotechnology;2019-07-26
3. New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled Trials;Journal of Clinical and Experimental Hepatology;2019-07
4. Review on chemogenomic approaches towards hepatitis C viral targets;Journal of Cellular Biochemistry;2019-03-19
5. Intrinsic structural versatility of the highly conserved 412–423 epitope of the Hepatitis C Virus E2 protein;International Journal of Biological Macromolecules;2018-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3